GlassScriptPhysician profile
Troy H Niguidula
NPI 1215948849
$3,602.08
in general payments reported to CMS, 2019-2025
41 companies · $475 in 2025
The $475 reported for 2025 was more than what 78% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $617 · 2020: $680 · 2021: $897 · 2022: $360 · 2023: $246 · 2024: $327 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,048.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,048.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $482.74 | 2019-2024 | Jardiance, Mounjaro, Trulicity |
| Novartis Pharmaceuticals Corporation | $238.98 | 2019-2023 | |
| Novo Nordisk INC | $237.07 | 2020-2023 | Wegovy |
| Astrazeneca Pharmaceuticals LP | $236.94 | 2019-2024 | Airsupra |
| Glaxosmithkline, LLC. | $207.03 | 2021-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $183.48 | 2021-2025 | |
| Sunovion Pharmaceuticals INC. | $180.29 | 2019 | |
| Heartflow, INC. | $174.83 | 2025 | |
| Pfizer INC. | $146.74 | 2019-2025 | |
| Abbvie INC. | $135.01 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $109.76 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $100.18 | 2020-2025 | Jardiance, Tradjenta |
| Boston Scientific Corporation | $85.39 | 2019-2025 | Watchman Flx |
| Merck Sharp & Dohme LLC | $78.22 | 2019-2021 | |
| Mylan Specialty L.P. | $74.46 | 2019-2022 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Niguidula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.